Design, Synthesis, and Investigation of Novel Nitric Oxide (NO)-Releasing Aromatic Aldehydes as Drug Candidates for the Treatment of Sickle Cell Disease
Boshi Huang(Virginia Commonwealth University), Martin K. Safo(Virginia Commonwealth University), Faik N. Musayev(Virginia Commonwealth University), Rana T. Alhashimi(Virginia Commonwealth University), Akua K. Donkor(Virginia Commonwealth University), Marilyn J. Telen(Duke University), Mohini S. Ghatge(Children's Hospital of Philadelphia), Osheiza Abdulmalik(Children's Hospital of Philadelphia), T. McMahon(Durham VA Health Care System), Abdelsattar M. Omar(Al-Azhar University), Yan Zhang(Virginia Commonwealth University), Tanvi Deshpande(Virginia Commonwealth University), Hongmei Zhu(Sichuan University), Mohammed A. AlAwadh(Virginia Commonwealth University)
Cited by 6
Related Papers
Blood Flow Regulation by <i>S</i> -Nitrosohemoglobin in the Physiological Oxygen Gradient
|Science|1997|1.1k
In vivo hematopoietic stem cell modification by mRNA delivery
|Science|2023|321
An Official American Thoracic Society Clinical Practice Guideline: Diagnosis, Risk Stratification, and Management of Pulmonary Hypertension of Sickle Cell Disease
|American Journal of Respiratory and Critical Care Medicine|2014|256
5‐hydroxymethyl‐2‐furfural modifies intracellular sickle haemoglobin and inhibits sickling of red blood cells<sup>†,‡</sup>
|British Journal of Haematology|2005|244
Sphingosine-1-phosphate promotes erythrocyte glycolysis and oxygen release for adaptation to high-altitude hypoxia
|Nature Communications|2016|212